Approval Details
The Nomination and Remuneration Committee of the Board of Directors approved the allotment via Circular Resolution on 16th November, 2026.
Allotment Details
- Total equity shares allotted: 5,23,989 (Five Lakhs Twenty-Three Thousand Nine Hundred and Eighty-Nine)
- Face value: ₹2 per share
- Recipients: Eligible employees of the Company
Share Characteristics
The newly allotted shares will rank pari-passu with existing shares of the Company in all respects.
Capital Structure Impact
Consequent to the allotment:
- Pre-allotment equity shares: 19,52,78,626 shares
- Post-allotment equity shares: 19,58,02,615 shares
- Increase of 5,23,989 shares
ESOP Scheme Details
Exercise Price Breakdown
The options were exercised at five different price points:
- 744 shares at ₹16 per share
- 9,634 shares at ₹24 per share
- 3,25,881 shares at ₹40 per share
- 95,550 shares at ₹50 per share
- 92,180 shares at ₹96 per share
Financial Proceeds
Total money realized by exercise of options: ₹2,69,05,140 (excluding tax)
Scheme Compliance
The scheme is in terms of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
Significant Terms
- The equity shares arising on exercise of options rank pari-passu with all other equity shares
- No lock-in restrictions except those imposed by applicable laws
Earnings Impact
The diluted earnings per share for the year ended 31 March 2026 is ₹1.75 per share.
Additional Information
- Options vested: 5,23,989 (Vesting Schedule: Not Applicable)
- Exercise period: Not Applicable
- Options lapsed: Not Applicable
- Variation of terms: Not Applicable
- Subsequent changes/cancellation: Not Applicable